Czibere Akosinsider trades
In SEC Form 4 filings, Czibere Akos is listed as Chief Medical Officer of Aktis Oncology, Inc. (AKTS). In the last 90 days, Czibere Akos sold $258.6K of Aktis Oncology, Inc. (AKTS) on the open market and bought none. All 2 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| AKTSAktis Oncology, Inc. | Chief Medical Officer | 4 | Sep 24 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-24
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| AKTSAktis Oncology, Inc. | Sep 23 | Sep 24 | M | 12,500 | $4.95 | $61,875 | 12,500 | Yes | Form 4 |
| AKTSAktis Oncology, Inc. | Sep 23 | Sep 24 | S | 5,099 | $20.19 | Sale −$102,973 | 7,401 | Yes | Form 4 |
| AKTSAktis Oncology, Inc. | Sep 23 | Sep 24 | S | 7,401 | $21.03 | Sale −$155,648 | not reported | Yes | Form 4 |
| AKTSAktis Oncology, Inc. | Sep 23 | Sep 24 | M · derivative | 12,500 | $4.95 | $61,875 | 208,718 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.